Variation in the observed effect of Xpert MTB/RIF testing for tuberculosis on mortality: A systematic review and analysis of trial design considerations [version 2; peer review: 2 approved]
Background: Most studies evaluating the effect of Xpert MTB/RIF testing for tuberculosis (TB) concluded that it did not reduce overall mortality compared to usual care. We conducted a systematic review to assess whether key study design and execution features contributed to earlier identification of...
Main Authors: | Eleanor A. Ochodo, Nelson Kalema, Samuel Schumacher, Karen Steingart, Taryn Young, Susan Mallett, Jon Deeks, Frank Cobelens, Patrick M. Bossuyt, Mark P. Nicol, Adithya Cattamanchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wellcome
2020-08-01
|
Series: | Wellcome Open Research |
Online Access: | https://wellcomeopenresearch.org/articles/4-173/v2 |
Similar Items
-
Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda.
by: Christina Yoon, et al.
Published: (2012-01-01) -
Management of false-positive rifampicin resistant Xpert MTB/RIF
by: Natalie Beylis, et al.
Published: (2020-10-01) -
Improving the design of studies evaluating the impact of diagnostic tests for tuberculosis on health outcomes: a qualitative study of perspectives of diverse stakeholders [version 1; peer review: 2 approved]
by: Eleanor A. Ochodo, et al.
Published: (2019-11-01) -
Population-level impact of same-day microscopy and Xpert MTB/RIF for tuberculosis diagnosis in Africa.
by: David W Dowdy, et al.
Published: (2013-01-01) -
Клиническая эффективность теста Xpert MTB/RIF
Published: (2015-07-01)